Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

被引:0
|
作者
Maroto, Irene B.
Moreno, Estefania [4 ,5 ]
Costas-Insua, Carlos [1 ,2 ,3 ]
Merino-Gracia, Javier [1 ]
Diez-Alarcia, Rebeca [6 ,7 ,8 ]
Alvaro-Blazquez, Alicia
Canales, Angeles [9 ]
Canela, Enric I. [4 ,5 ]
Casado, Vicent [4 ,5 ]
Uriguen, Leyre [6 ,7 ,8 ]
Rodriguez-Crespo, Ignacio [1 ,2 ,3 ]
Guzman, Manuel [1 ,2 ,3 ]
机构
[1] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Biochem & Mol Biol, Madrid 28040, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28029, Spain
[3] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain
[4] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[5] Univ Barcelona, Inst Biomed, Barcelona 08028, Spain
[6] Univ Basque Country, Dept Pharmacol, Euskal Herriko Unibertsitatea, Leioa 48940, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid 28029, Spain
[8] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Bizkaia, Spain
[9] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Organ Chem, Madrid 28040, Spain
关键词
Cell signalling; CannabinoidCB1; receptor; Growth-associated protein of 43 kDa; Rho-associated coiled-coil containing protein; kinase; GAP-43; NEUROMODULIN; NEURITE OUTGROWTH; GROWTH; ACTIVATION; BRAIN; PHOSPHORYLATION; INTERNALIZATION; CANCER; CELLS; LOGIC;
D O I
10.1016/j.neuropharm.2023.109712
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids exert pleiotropic effects on the brain by engaging the cannabinoid CB1 receptor (CB1R), a pre -synaptic metabotropic receptor that regulates key neuronal functions in a highly context-dependent manner. We have previously shown that CB1R interacts with growth-associated protein of 43 kDa (GAP43) and that this interaction inhibits CB1R function on hippocampal excitatory synaptic transmission, thereby impairing the therapeutic effect of cannabinoids on epileptic seizures in vivo. However, the underlying molecular features of this interaction remain unexplored. Here, we conducted mechanistic experiments on HEK293T cells co -expressing CB1R and GAP43 and show that GAP43 modulates CB1R signalling in a strikingly selective manner. Specifically, GAP43 did not affect the archetypical agonist-evoked (i) CB1R/Gi/o protein-coupled sig-nalling pathways, such as cAMP/PKA and ERK, or (ii) CB1R internalization and intracellular trafficking. In contrast, GAP43 blocked an alternative agonist-evoked CB1R-mediated activation of the cytoskeleton-associated ROCK signalling pathway, which relied on the GAP43-mediated impairment of CB1R/Gq/11 protein coupling. GAP43 also abrogated CB1R-mediated ROCK activation in mouse hippocampal neurons, and this process led in turn to a blockade of cannabinoid-evoked neurite collapse. An NMR-based characterization of the CB1R-GAP43 interaction supported that GAP43 binds directly and specifically through multiple amino acid stretches to the C -terminal domain of the receptor. Taken together, our findings unveil a CB1R-Gq/11-ROCK signalling axis that is selectively impaired by GAP43 and may ultimately control neurite outgrowth.
引用
收藏
页数:13
相关论文
共 47 条
  • [1] Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
    Maroto, Irene B.
    Costas-Insua, Carlos
    Berthoux, Coralie
    Moreno, Estefania
    Ruiz-Calvo, Andrea
    Montero-Fernandez, Carlos
    Macias-Camero, Andrea
    Martin, Ricardo
    Garcia-Font, Nuria
    Sanchez-Prieto, Jose
    Marsicano, Giovanni
    Bellocchio, Luigi
    Canela, Enric I.
    Casado, Vicent
    Galve-Roperh, Ismael
    Nunez, Angel
    Fernandez de Sevilla, David
    Rodriguez-Crespo, Ignacio
    Castillo, Pablo E.
    Guzman, Manuel
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
    Smith, Tricia H.
    Blume, Lawrence C.
    Straiker, Alex
    Cox, Jordan O.
    David, Bethany G.
    Mcvoy, Julie R. Secor
    Sayers, Katherine W.
    Poklis, Justin L.
    Abdullah, Rehab A.
    Egertova, Michaela
    Chen, Ching-Kang
    Mackie, Ken
    Elphick, Maurice R.
    Howlett, Allyn C.
    Selley, Dana E.
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 747 - 765
  • [3] Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer
    Cipriano, Mariateresa
    Haggstrom, Jenny
    Hammarsten, Peter
    Fowler, Christopher J.
    PLOS ONE, 2013, 8 (06):
  • [4] Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
    Blume, Lawrence C.
    Patten, Theresa
    Eldeeb, Khalil
    Leone-Kabler, Sandra
    Ilyasov, Alexander A.
    Keegan, Bradley M.
    O'Neal, Jeremy E.
    Bass, Caroline E.
    Hantgan, Roy R.
    Lowther, W. Todd
    Selley, Dana E.
    Howlett, Allyn C.
    MOLECULAR PHARMACOLOGY, 2017, 91 (02) : 75 - 86
  • [5] In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b)-CB1 cannabinoid receptor
    Singh, Pratishtha
    Ganjiwale, Anjali
    Howlett, Allyn C.
    Cowsik, Sudha M.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2017, 77 : 311 - 321
  • [6] Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus
    Guggenhuber, Stephan
    Alpar, Alan
    Chen, Rongqing
    Schmitz, Nina
    Wickert, Melanie
    Mattheus, Tobias
    Harasta, Anne E.
    Purrio, Martin
    Kaiser, Nadine
    Elphick, Maurice R.
    Monory, Krisztina
    Kilb, Werner
    Luhmann, Heiko J.
    Harkany, Tibor
    Lutz, Beat
    Klugmann, Matthias
    BRAIN STRUCTURE & FUNCTION, 2016, 221 (04) : 2061 - 2074
  • [7] Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners
    Esteban, Pedro F.
    Garcia-Ovejero, Daniel
    Paniagua-Torija, Beatriz
    Moreno-Luna, Rafael
    Arredondo, Luis F.
    Zimmer, Andreas
    Arevalo Martin, Angel
    Molina-Holgado, Eduardo
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 337
  • [8] Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling
    Bosier, Barbara
    Doyen, Pierre J.
    Brolet, Amandine
    Muccioli, Giulio G.
    Ahmed, Eman
    Desmet, Nathalie
    Hermans, Emmanuel
    Deumens, Ronald
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (22) : 5333 - 5346
  • [9] Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands
    Di Marzo, V
    Bisogno, T
    De Petrocellis, L
    Brandi, I
    Jefferson, RG
    Winckler, RL
    Davis, JB
    Dasse, O
    Mahadevan, A
    Razdan, RK
    Martin, BR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) : 444 - 451
  • [10] Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor
    Garcia, DE
    Brown, S
    Hille, B
    Mackie, K
    JOURNAL OF NEUROSCIENCE, 1998, 18 (08) : 2834 - 2841